Most if not all diagnostic radiologists should be capable of performing numerous image-guided procedures, according to a task force jointly convened by the American College of Radiology and the Society of Interventional Radiology.

No. 4: Amgen supplies HHS with drug used to fight blood cell injuries from acute radiation syndrome in radiological and nuclear emergencies (Oct. 4).

In the U.K., two instances of evidently inept work by radiologists are inadvertently spotlighting the value of subspecialized image interpretation in socially sensitive patient cases.

Stamatia Destounis, MD, FACR, a radiologist and managing partner at Elizabeth Wende Breast Care in Rochester, New York, and chair of the ACR Breast Commission, discusses post-COVID-19 economic issues facing breast imaging centers, including staffing problems from the "Great Resignation" and lower reimbursements. 

A global tech and pharma supplier that introduced a generic equivalent to GE Healthcare’s Visipaque during the height of the 2022 contrast shortage has begun offering a substitute for Guerbet’s Dotarem.

Why are patients paying far less out of their pockets for mammography now than two decades ago—while shelling out a lot more for other common imaging exams?

Nearly 30% of corresponding authors included in the analysis shared that they had witnessed scientific fraud in their department within the last five years.

While the Biden administration and federal agencies have made price transparency a long-term goal for the U.S. healthcare industry, a recent study revealed Americans aren’t actually shopping around very often for better healthcare prices.